Parkinsonian Syndrome

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2017-09-13
Clinical Trial Update: A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes [Phase 3]
Phase 3 trial evaluating [123I]NAV5001 for imaging Parkinsonian syndromes was withdrawn.